Unknown

Dataset Information

0

High Concentrations of Polyelectrolyte Complex Nanoparticles Decrease Activity of Osteoclasts.


ABSTRACT: Fracture treatment in osteoporotic patients is still challenging. Osteoporosis emerges when there is an imbalance between bone formation and resorption in favor of resorption by osteoclasts. Thus, new implant materials for osteoporotic fracture treatment should promote bone formation and reduce bone resorption. Nanoparticles can serve as drug delivery systems for growth factors like Brain-Derived Neurotrophic Factor (BDNF), which stimulated osteoblast differentiation. Therefore, polyelectrolyte complex nanoparticles (PEC-NPs) consisting of poly(l-lysine) (PLL) and cellulose sulfate (CS), with or without addition of BDNF, were used to analyze their effect on osteoclasts in vitro. Live cell images showed that osteoclast numbers decreased after application of high PLL/CS PEC-NPs concentrations independent of whether BDNF was added or not. Real-time RT-PCR revealed that relative mRNA expression of cathepsin K and calcitonin receptor significantly declined after incubation of osteoclasts with high concentrations of PLL/CS PEC-NPs. Furthermore, Enzyme-Linked Immunosorbent Assay indicated that tartrate-resistant acidic phosphatase 5b activity was significantly reduced in the presence of high PLL/CS PEC-NPs concentrations. Consistent with these results, the pit formation analysis showed that less hydroxyapatite was resorbed by osteoclasts after incubation with high concentrations of PLL/CS PEC-NPs. BDNF had no influence on osteoclasts. We conclude that highly concentrated PLL/CS PEC-NPs dosages decreased osteoclastogenesis and osteoclasts activity. Moreover, BDNF might be a promising growth factor for osteoporotic fracture treatment since it did not increase osteoclast activity.

SUBMITTER: Kauschke V 

PROVIDER: S-EPMC6630339 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

High Concentrations of Polyelectrolyte Complex Nanoparticles Decrease Activity of Osteoclasts.

Kauschke Vivien V   Hessland Felix Maximilian FM   Vehlow David D   Müller Martin M   Heiss Christian C   Lips Katrin Susanne KS  

Molecules (Basel, Switzerland) 20190625 12


Fracture treatment in osteoporotic patients is still challenging. Osteoporosis emerges when there is an imbalance between bone formation and resorption in favor of resorption by osteoclasts. Thus, new implant materials for osteoporotic fracture treatment should promote bone formation and reduce bone resorption. Nanoparticles can serve as drug delivery systems for growth factors like Brain-Derived Neurotrophic Factor (BDNF), which stimulated osteoblast differentiation. Therefore, polyelectrolyte  ...[more]

Similar Datasets

| S-EPMC7285317 | biostudies-literature
| S-EPMC3037278 | biostudies-literature
| S-EPMC7865910 | biostudies-literature
| S-EPMC6893948 | biostudies-literature
| S-EPMC7557399 | biostudies-literature
| S-EPMC6402027 | biostudies-literature
| S-EPMC6470925 | biostudies-literature
| S-EPMC6431993 | biostudies-literature
| S-EPMC1185780 | biostudies-other
| S-EPMC7448379 | biostudies-literature